Clinical Trial Update: Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the safety and efficacy of Quisinostat in combination with chemotherapy for ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Quisinostat (quisinostat)

Snippet

Sponsor: NewVac LLC | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED